首页> 外国专利> METHOD FOR INDUCING A CELL-MEDIATED IMMUNE RESPONSE AND PARENTERAL VACCINE FORMULATIONS THEREFOR

METHOD FOR INDUCING A CELL-MEDIATED IMMUNE RESPONSE AND PARENTERAL VACCINE FORMULATIONS THEREFOR

机译:诱导细胞介导的免疫反应的方法和腹膜炎疫苗制剂

摘要

A method of inducing either a T H1 polarised immune response, a T H2 polarised immune response or a combined T H1 and T H2 response to an antigen and associated vaccine formulations are disclosed. A method is provided for inducing a polarised TH 1 response by parenteral administration of microparticles sized such that at least 50% of the microparticles are less than 5 µm, the microparticles containing antigen entrapped or encapsulated by a biodegradable polymer. Additionally, a method is provided for inducing a polarised T H2 response by parenteral administration of nanoparticles sized such that at least 50% of the nanoparticles are less than 600 nm, the nanoparticles containing antigen entrapped or encapsulated by a biodegradable polymer. Vaccine formulations containing the B.pertussis antigens PTd, FHA or a combination of PTd and FHA are provided.
机译:公开了一种诱导针对抗原的T H1极化的免疫应答,T H2极化的免疫应答或组合的T H1和T H2应答的方法,以及相关的疫苗制剂。提供了一种通过肠胃外施用尺寸至少使得至少50%的微粒小于5μm的微粒引起的极化的TH 1反应的方法,所述微粒包含被可生物降解的聚合物截留或包封的抗原。另外,提供了一种通过肠胃外施用纳米粒子来诱导极化的TH 2反应的方法,所述纳米粒子的尺寸使得至少50%的纳米粒子小于600nm,所述纳米粒子包含被可生物降解的聚合物包裹或包封的抗原。提供了含有百日咳博德特氏菌抗原PTd,FHA或PTd和FHA的组合的疫苗制剂。

著录项

  • 公开/公告号CA2731995C

    专利类型

  • 公开/公告日2013-05-28

    原文格式PDF

  • 申请/专利权人 MERRION RESEARCH III LIMITED;

    申请/专利号CA19992731995

  • 发明设计人 BRAYDEN DAVID JAMES;

    申请日1999-08-31

  • 分类号A61K9/50;A61K9/16;A61K39;A61K39/10;A61K47/34;A61P37/04;

  • 国家 CA

  • 入库时间 2022-08-21 16:38:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号